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TONY BARNETT
Economists tend to see the impact of
AIDS in terms of money values, but
that isn’t good enough.
In this research I am exploring how we can move away
from the idea that costs can only be measured in dollars
or pounds and to look at what the loss of a parent – or
the inability to work because of AIDS-related illness –
really means to an individual and to society as a whole.
What it boils down to is: how do you measure the value
of love? What is the value of a cuddle to an orphaned
child? Over the past 20 years, since I published AIDS in
Africa: Its present and future impacts, I have been involved
with over 50 research projects in the field of the social
and economic impact of HIV/AIDS. I am convinced
that quantitative accounts of the effects of the
HIV/AIDS epidemic using standard economic
approaches based on cost do not capture its impacts on
societies and economies and therefore misinform
allocative decisions by policy makers.  
My research focuses on trying to find ways of
incorporating qualitative factors into impact
assessment and policy making. An HIV/AIDS epidemic
has very important social and economic implications
for development because it is mainly sexually
transmitted and because of the age-specific incidence
of the disease. Unlike other epidemics it mainly affects
young and mature adults more than other members of
society. It therefore affects the structure of populations,
increasing the ratio of dependants to productive
citizens, and unbalances the supply and quality of
labour. For example, a young man of 15 in Botswana
today is close to 100 per cent likely to contract HIV
infection in his lifetime. One should think what that
means for economic, cultural and political futures: in
other words, for that elusive thing called
‘development’. It seems likely that effective rollout of
antiretroviral treatments will only provide a window of
opportunity lasting between five and ten years before
viral resistance kicks in. How soon and whether
depends on the effectiveness and sustainability of
treatment programmes. We need to have the
surveillance and response systems in place soon to deal
with that challenge.  
The HIV epidemic is one example of our inability to
engage with large-scale events.  Over the last 20 years,
funding limitations have caused development policy to
be increasingly concerned with the minutiae of the
immediate present. One result is that very big issues
challenging progress towards, for example, the
Millennium Development Goals have often received
scant attention. Nowhere is this more apparent than
with regard to HIV/AIDS and the associated issues it
raises. HIV/AIDS is far more than a public health issue:
there are few problems in development policy that do
not have an AIDS angle, whether we think of livelihood
analysis, gender studies, macroeconomic and trade
policy, intellectual property rights issues, cultural
analysis of change, policy development or myriad other
areas. One reason why the medium- and long-terms
effects of HIV/AIDS are not well understood is that the
current prevalence of HIV positivity (seroprevalence) is
an indication of the future, some eight to 20 years
ahead. This means that the social and economic costs
and other impacts of the high levels of current
prevalence (now in the 25–40 per cent range in central
and southern Africa, above 1 per cent in Russia,
Ukraine and Estonia, and approaching 10 per cent in
some Indian states) will not be seen for some years to
come. But the epidemic has already had devastating
effects in many areas of sub-Saharan Africa. Medical
services are at breaking point and there is large-scale
orphaning and destitution. Food security is under
threat because of the loss of agricultural workers and
industrial production is also at risk, particularly in
Botswana, where seroprevalence has exceeded 35 per
cent in some companies. However, in a relatively rich
country where antiretroviral therapy can be provided
free or very nearly free, this challenge is being met. This
is not the case in many other countries. 
But this research is showing how the greatest costs are
those borne by families, communities and whole nations
as the relations and links of trust that make markets and
politics possible break down. Losses in the informal and
‘trust’ economies are probably of even greater import
than losses to production and productivity in the formal
economy. What is the effect on national life of loss of
local politicians who die prematurely, resulting in more
frequent elections with consequent choice of less and
less experienced incumbents?
The project will makes particular reference to Russia
and Africa, which are at very different stages of the
epidemic. Although supported by some fieldwork, in
the main this work draws on existing data from a range
of academic disciplines, and questions accepted
concepts such as ‘cost’, ‘responsibility’ and ‘impact’.  It
is essentially a theoretical project, but some fieldwork
has been done in South Africa, Uganda, the USA 
and Russia. 
Tony Barnett is an ESRC Professorial Research Fellow at
the London School of Economics and founder of LSEAIDS.
He is co-author (with Alan Whiteside) of AIDS in the 21st
Century: Disease and globalisation, London and New York:
Palgrave Macmillan; 2006 (E a.s.barnett@lse.ac.uk).
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The development of modern surgery
was driven by the increasing demand
for well-trained medical personnel able
to attend the soldiers in the several
fronts opened in Europe. The Royal
Colleges of Surgery are seen as the
more important enlightened medical
institutions created by the Spanish
Borbonic monarchy.
The Royal College of Surgery of Barcelona was the
second such college created in Spain, founded in 1760.
Its Catalan location placed it near French and among
Spanish military forces. It is relevant to take into
account that from 1714, the Borbonic monarchy had
closed all the universities in Catalonia – the University
of Barcelona included – for political reasons, and built a
new university in the more remote town of Cervera.
The only institution in the principality where an
academic degree related to health could be obtained
was the Royal College of Surgery of Barcelona. Indeed,
the students of medicine from the University of
Cervera had to practise anatomy in the College. 
The academic programme developed in the new
colleges of surgery was different from the traditional
formal education for surgeons. As the Barcelona
College was erected next to the Hospital of Santa Creu
(founded in 1401), there was a give-and-take between
the two. On the one hand, the professors of the College
had to work in the Hospital too; on the other hand, the
Hospital supplied the patients and corpses to be
studied. Moreover, the new physician-surgeons trained
there not only were interested in therapeutics but also
wanted to know as much as possible about the body’s
anatomy and physiology, being as they were in
competition with its pathology.
As a result of this, at the end of the 18th century and the
early 19th century, surgeons, physicians and pharmacists
were gathered together in the so-called ‘Facultad Reunida’,
which experienced several organisational problems
during the following years. Eventually, in the middle of
the 19th century, surgeons and physicians were rejoined
in the University of Barcelona’s Faculty of Medicine when
this university had its rights and funding reinstated. But it
is important to take into account the dual condition of the
physician-surgeons trained in the College of Barcelona.
In this setting, a new form of transmission of knowledge
– and indeed a new method of teaching – was proposed
in the regulations of the new colleges of surgeons in
Spain (a similar process was underway in other
enlightenment scientific institutions of this period, for
instance societies and academies). These regulations
established the ‘junta literaria’: a dissertation would be
read and then criticised in a public session with both the
students and the board of professors of the college. Then,
the following week, another professor was charged by
the vice-president of the college with elaborating a
critical assessment, reading in public session again, plus
a critical writing about the dissertation. At the end of the
session, each professor on the board would give a short
written assessment or comment. It is important to stress
that these manuscripts are available in the archives and
constitute the most important primary source of my
research, which examines the role and the reception of
the new sciences applied to healing arts.
This documentation makes it clear that chemistry 
came to be especially prominent in the dissertations
expounded at the Royal College of Surgery of
Barcelona. By the beginning of the 19th century
chemistry had already achieved its own language: a
new nomenclature and several gases had been
characterised, the theory of combustion had been
enounced and laboratory experimentation constituted
a common scientific practice. Chemistry should be
considered as a professional, liberal, useful activity,
with a continuum from research papers, reviews and
textbooks to its proper diffusion. In this sense, my work
aims to show how chemistry was included in the
academic programmes of the Spanish Royal Colleges of
Surgery, and how chemistry in this medical–surgical
context could have been a crucial tool to understand
the unexplained processes that happened in the
human body, in sickness and in health. 
The development of the study of airs crossed the
boundaries between chemistry, physics and medicine.
For example, the therapeutic use of aerostatic balloons
Medicine and science in a new 
medical–surgical context: the Royal College 
of Surgery of Barcelona (1760–1843)
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